Clinical Trials Logo

Radiculopathy Lumbar clinical trials

View clinical trials related to Radiculopathy Lumbar.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06421558 Recruiting - Clinical trials for Radiculopathy Lumbar

Impact of Direct Current Electrical Stimulation on Treatment of Lumbosacral Radiculopathy

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

This study will compare two methods of electrical stimulation (alternating current and direct current) as an adjunctive therapy to treating lumbosacral radiculopathy. Both types of electrical stimulation have been used in clinical practice for physical therapy, however direct current stimulation is much less common and there is less known about its impact on physical therapy outcomes. The aim of this project is to show the efficacy of a novel device, the Neubie direct current device, compared to traditional TENS unit in clinical physical therapy treatment of radiculopathy. Outcomes measured will include: pain intensity, functional status, neurological status, electrophysiological changes and patient satisfaction.

NCT ID: NCT06143813 Recruiting - Herniated Disc Clinical Trials

Precision Treatment of Lumbar Spine Surgery Through Advanced Nerve Root Blockade

PLAN
Start date: November 9, 2023
Phase: N/A
Study type: Interventional

The overall purpose of the study is to investigate whether selective spinal nerve root blocks can improve diagnostics of radiculopathy due to lumbar disc herniation (LDH), foraminal stenosis (FS), and recess stenosis (RS), and hence identify the patients that will benefit from surgical intervention.

NCT ID: NCT05923736 Recruiting - Osteoporosis Clinical Trials

Cardiovascular Risk in Digital Osteoarthritis

RICARDI
Start date: October 4, 2023
Phase: N/A
Study type: Interventional

The goal of this cross-sectional case control study is to investigate the cardiovascular risk in digital osteoarthritis. This study aims to compare the cardiovascular risk between group of patients with digital osteoarthritis and control group of patients with non-osteoarthritis disease paired by measurement of carotid intima-media thickness. All participants will undergo an ultrasound scan to measure carotid intima media thickness, a clinical assessment with the rheumatologist and a cardiovascular risk assessment.

NCT ID: NCT05261581 Recruiting - Radiculopathy Clinical Trials

Evaluation of Erector Spina Plane Block(ESPB)'s Effectiveness on Patients With Lumbar Radiculopathy

Start date: March 1, 2022
Phase: Early Phase 1
Study type: Interventional

A new regional anaesthetic block technique is described in this issue of Anaesthesia by Chin et al. whereby local anaesthetic is injected within a plane beneath the erector spinae muscle to achieve analgesia for abdominal surgery. After this the block has been used successfully for many implications such as post-herpetic neuralgia, thoracic and abdominal chronic or acute pain management, rib fractures, breast surgery, chronic cancer pain and etc. Cadaveric and radiologic data showed that contrast injected into the tissue plane deep to erector spinae muscle and superficial to the transverse processes and intertransverse connective tissues penetrates anteriorly to anesthetize the spinal nerves. And some cadeveric studies resulted with where both the dorsal and ventral rami of the thoracic spinal nerves were marked with dye after ESPB. Some studies even showed that dye reached to the epidural space. In this manner we we hypothesize that ESPB could be effective with radiculopathy pain.

NCT ID: NCT04054401 Recruiting - Chronic Pain Clinical Trials

SynerFuse Spinal Fusion and Neuromodulation Proof of Concept Study

Start date: January 6, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the safety and tolerability of DRG stimulation when placing a neurostimulator during the same procedure as implantation of spinal fixation with or without interbody cage systems in patients with chronic back and/or leg pain requiring single level spinal fusion.

NCT ID: NCT03502057 Recruiting - Clinical trials for Degenerative Disc Disease

P-15L Bone Graft Lumbar Fusion Clinical Trial

Start date: August 1, 2018
Phase: N/A
Study type: Interventional

Study Design: Prospective, single-blinded, multi-center, randomized, controlled, pivotal study Study Objective: To evaluate if P-15L is not inferior in effectiveness and safety to local autologous bone (and allograft as extender where necessary) when applied in instrumented TLIF in subjects with Degenerative disc disease (DDD) Study Endpoints: Primary endpoint: Month 24 Composite Clinical Success (CCS): - Achievement of fusion (Evidence of continuous trabecular bridging bone in the intervertebral space) - At least 15-point improvement in Oswestry Disability Index (ODI) - No new or worsening, persistent neurological deficit - No subsequent surgical intervention at the index level Once fusion is radiographically confirmed, it will be assumed that fusion has occurred at all subsequent time points without the need to reconfirm fusion status at later time points. Multiplicity Controlled Secondary endpoint: • Visit at which fusion is confirmed. Other Secondary endpoints: - Visual Analog Scale (VAS) pain scores, changes over time, and achievement of a 20 mm improvement (Back, left leg, right leg); - Physical Function and Mental Health Composite Scores (Short Form Health Survey SF-12 and changes over time).